Spots Global Cancer Trial Database for NEUWAVE Flexible Probe Study #2

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: NEUWAVE Flexible Probe Study #2

Official Title: A Multicenter Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Secondary Soft Tissue Lesions of the Lung

Study ID: NCT03713099

Conditions

Cancer of the Lung

Lung Cancer

Neoplasms, Lung

Carcinoma, Non-Small Cell Lung

Non-Small Cell Lung Cancer

Non-Small Cell Lung Carcinoma

Interventions

Microwave ablation

Study Description

Brief Summary: Patients with medically inoperable and operable secondary soft tissue lesion(s) of the lung will have transbronchial microwave ablation performed using cone beam CT for probe guidance and confirmation.

Detailed Description: Adult patients with medically inoperable and operable secondary soft tissue lesion(s) of the lung less than 2cm will undergo transbronchial microwave ablation performed by an interventional pulmonologist or thoracic surgeon using cone beam CT imaging for probe guidance and confirmation on ablation outcome. All treated patients will be followed for one year following the ablation procedure for efficacy and safety.